AUGUSTA — Maine’s attorney general says Maine is joining other states and the federal government in reaching a $520 million settlement with pharmaceutical manufacturer AstraZeneca, resolving allegations surrounding the company’s promotion of anti-psychotic drug Seroquel.

The case involves AstraZeneca promoting Seroquel for uses that are not approved by federal drug regulators, including insomnia and psychiatric conditions besides schizophrenia and bipolar disorder.

Attorney General Eric Holder announced Tuesday that the federal government a reached a settlement with the company.

Maine Attorney General Janet T. Mills says the state will receive over $1.2 million in restitution and additional recoveries.

Only subscribers are eligible to post comments. Please subscribe or to participate in the conversation. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.